drugset / Trial / NCT00828464

Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis

NCT00828464

Phase 4 Completed 30 enrolled Stiefel, a GSK Company GlaxoSmithKline · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to assess the safety, efficacy and tolerability of Clobetasol propionate foam in subjects with chronic dermatitis.

Timeline

Start
2008-10
Primary completion
2009-01
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Subject clobetasol propionate Small molecule 0.05 % Topical

Indications